U2Bio Co., Ltd. (KOSDAQ:221800)
22,900
+1,000 (4.57%)
At close: Mar 9, 2026
U2Bio Market Cap
U2Bio has a market cap or net worth of 364.85 billion as of March 9, 2026. Its market cap has increased by 1,026.29% in one year.
Market Cap
364.85B
Enterprise Value
334.91B
Revenue
25.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
22,900.00
Market Cap Chart
Since April 3, 2017, U2Bio's market cap has increased from 28.86B to 364.85B, an increase of 1,164.43%. That is a compound annual growth rate of 32.83%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| YG-1 Co., Ltd. | 349.99B |
| KOLMAR BNH | 347.74B |
| Sang-A Frontec | 347.67B |
| Value Added Technology | 347.59B |
| Galaxia Moneytree | 346.40B |
| InBody Co.,Ltd | 352.36B |
| SBB Tech | 344.56B |
| OKins Electronics | 344.19B |